Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract...

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First...

COMPASS Pathways plc to announce fourth quarter and full year 2020...

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine...

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Psychedelics Company Silo Wellness Inc. (Formerly Yukoterre Resources Inc.) Announces Successful...

Finding the Psychedelic Sweet Spot

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second...

Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with...

Load more